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Lymphocyte-specific protein-tyrosine kinase (Lck) plays an
essential role in T cell receptor (TCR) signaling andT cell devel-
opment, but its activation mechanism is not fully understood.
To explore the possibility that plasma membrane (PM) lipids
control TCR signaling activities of Lck, we measured the mem-
brane binding properties of its regulatory Src homology 2 (SH2)
and Src homology 3 domains. The Lck SH2 domain binds ani-
onic PM lipids with high affinity but with low specificity. Elec-
trostatic potential calculation, NMR analysis, and mutational
studies identified the lipid-binding site of the Lck SH2 domain
that includes surface-exposed basic, aromatic, and hydrophobic
residues but not the phospho-Tyr binding pocket. Mutation of
lipid binding residues greatly reduced the interaction of Lck
with the  chain in the activated TCR signaling complex and its
overall TCR signaling activities. These results suggest that PM
lipids, including phosphatidylinositol 4,5-bisphosphate and
phosphatidylinositol 3,4,5-trisphosphate, modulate interaction
of Lck with its binding partners in the TCR signaling complex
and its TCR signaling activities in a spatiotemporally specific
manner via its SH2 domain.
Lymphocyte-specific protein-tyrosine kinase (Lck) is a
56-kDa Src family kinase that plays an essential role in T cell
receptor (TCR)4 signaling and T cell development (1, 2). In
response to TCR stimulation, Lck phosphorylates immunore-
ceptor tyrosine-based activation motifs (ITAMs) in the CD3
and the  chain of the TCR-CD3 complex, thereby contributing
to the initiation of TCR signaling (1, 2). This leads to ITAM
recruitment and activation of ZAP-70 that subsequently phos-
phorylates the linker for the activation of T cells and the Src
homology 2 (SH2) domain-containing leukocyte protein of 76
kDa (3). Phosphorylated linker for activation of T cells nucle-
ates the T cell signalosome, recruiting and activating further
downstream enzymes, including phospholipase C1 (PLC1)
(4, 5).
The enzymatic activity of Lck is regulated by phosphoryla-
tion and dephosphorylation of two Tyr residues, Tyr-394 and
Tyr-505 (1, 2, 4). It has been generally thought that Lck has a
similar activation mechanism to those of other Src family
kinases (6). In the resting state, Tyr-505 near the C terminus is
phosphorylated by C-terminal Src kinase, and the resulting
phospho-Tyr-505 (Tyr(P)-505) interacts with the SH2 domain,
leading to intramolecular tethering of its kinase domain, which
is further augmented by the Src homology 3 (SH3) domain-
kinase domain interaction. Upon TCR activation, CD45-medi-
ated dephosphorylation of Tyr(P)-505 unleashes the kinase
domain and primes Lck for full activation, which is thought to
require autophosphorylation of Tyr-394 within the activation
loop (7). More recent studies have revealed, however, that the
activation mechanism of Lck is more complex than originally
thought. For example, it has been reported that Lck can also
exist as an enzymatically active formwith Tyr-394 and Tyr-505
bothphosphorylated (Tyr(P)-394/Tyr(P)-505) and that Lck-de-
pendent tyrosine phosphorylation of TCR ITAMs does not
require enzyme activation of Lck but involves other mecha-
nisms, such as the membrane redistribution of active Lck or
ligand-mediated conformational changes of Lck (8–10). It was
also reported that Tyr-505 could be autophosphorylated by Lck
(10). These results suggest the possibility that other factors are
involved in Lck regulation under physiological conditions.
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Lck is constitutively localized via N-terminal acylation to the
plasma membrane (PM) where the TCR-CD3 complex is
located (1, 2). Thus, PM lipids might be involved in interaction
of Lck with the TCR-CD3 complex and its phosphorylation of
ITAMs. It was reported that CD3 chains bind anionic lipids in
the PM in resting T cells, thereby limiting the access of ITAMs
to Lck (11, 12). However, a more recent study reported that
ITAM phosphorylation by Lck was enhanced by an anionic
lipid, phosphatidylserine (10). Overall, the mechanism and the
physiological significance of Lck-lipid interaction in regulation
of Lck activity remain unknown.
The SH2 domain is a prototypical modular protein interac-
tion domain that has been identified in diverse cell-signaling
proteins, including kinases, adaptors, and phosphatases (13).
As a major reader of phosphotyrosine (Tyr(P)) signaling infor-
mation, SH2 domain-containing proteins play crucial roles in
linking various protein-tyrosine kinases to downstream mole-
cules, thereby controlling the specificity of Tyr(P) signaling
(14). Structural analysis of a wide range of SH2 domains and
their complexes with Tyr(P)-peptides has revealed that SH2
domains have a common architecture made of two -helices
(A and B) flanking antiparallel  strands (A to G) (13, 15).
They specifically recognize Tyr(P) and a few residues immedi-
ately C-terminal to Tyr(P) using a Tyr(P) binding pocket and a
secondary binding site, respectively (13).
It was reported earlier that a small number of SH2 domains
could bind lipids, which either inhibited (16) or promoted (17)
the activity of their host proteins, but the lipid-binding site and
the lipid specificity of these SH2 domains as well as the physi-
ological significance of these findings remain controversial
(18). More recently, genome-wide screening of PDZ (PSD95,
Dlg1, Zo-1) (19–21) and SH2 domains (22) revealed that a large
majority of these protein interaction domains bind PM lipids
with high affinity and that their lipid binding is crucial for the
cellular function of their host proteins. In this study, we
explored the possibility that lipids bind the Lck SH2 domain
(Lck-SH2) and control the cellular activity of Lck through this
interaction.
Results
Membrane Binding of Lck SH2 Domain—To quantitatively
assess the lipid binding activity and specificity of Lck-SH2, we
measured binding of Lck-SH2 to lipid vesicles with varying
compositions by SPR analysis. Because Lck-SH2 was not stably
expressed in Escherichia coli, we expressed it as a C-terminal
EGFP fusion protein, which generally improves the expression
yield of modular domains without interfering with their mem-
brane binding properties (23). Our control experiments
showed that the C-terminal EGFP tag did not affect the mem-
brane binding properties of Lck-SH2 (data not shown). Because
Lck is associated with the cytofacial leaflet of the PM, we first
used for binding measurements the vesicles whose lipid com-
position recapitulates that of the cytofacial PM (i.e.PMmimetic
vesicles) (24).
Quantitative determination of the affinity of Lck-SH2 for the
PMmimetic vesicles (Fig. 1, A and B, and Table 1) showed that
it had aKd of 160 15 nM for the PMmimetic vesicles, which is
comparable with that of other lipid-binding proteins (24),
including phospholipase C pleckstrin homology domain
(PLC-PH) (Table 1). This high affinity of Lck-SH2 for PM
mimetic vesicles is not due to nonspecific membrane adsorp-
tion because it was determined from the signal differences
between the two channels containing PMmimetic vesicles and
the neutral phosphatidylcholine vesicles, respectively. Also, the
Lck SH3 domain showed no detectable affinity for the PM
mimetic vesicles under the same conditions (data not shown).
Finally, Lck-SH2 and the full-length Lck had comparable affin-
ity for PMmimetic vesicles (Table 1), indicating that lipid bind-
ing activity of Lck lies within its SH2 domain and that the lipid-
binding site of Lck-SH2 is fully exposed in the intact protein.
We thendetermined the selectivity of Lck-SH2 for phosphoi-
nositides (PtdInsP), which play key roles in cell signaling (25).
When compared with canonical lipid binding domains with a
well defined lipid pocket, such as PLC-PH (Fig. 1F), Lck-SH2
showed a low degree of PtdInsP selectivity, modestly preferring
the most anionic PIP3 to other PtdInsPs (Fig. 1C). As expected
from its high affinity for PM mimetic vesicles that contain
PI4,5P2, Lck-SH2 bound PI4,5P2 slightly better than PI3,4P2
and PI3,5P2. Overall, it would seem that PtdInsP binding of
Lck-SH2 is driven primarily not by specific PtdInsP headgroup
recognition but by nonspecific electrostatic interactions.
To prove that PIP3 and PI4,5P2 play an important role in PM
localization of Lck-SH2, we measured the PM localization of
EGFP-tagged Lck-SH2 in response to PI4,5P2 and PIP3 deple-
tion (26, 27). Before treatment, Lck-SH2 showed PM localiza-
tion (Fig. 2A), albeit to a lesser degree than PLC-PH (Fig. 2B).
When PI4,5P2 depletion was triggered by a rapamycin analog,
Lck-SH2 (Fig. 2A) was rapidly removed from the PM, as was the
case with a prototypical PI4,5P2-selective protein, PLC-PH
(Fig. 2B). Also, PIP3 depletion by a PI3K inhibitor, LY294002,
greatly reduced the PM localization of Lck-SH2 (Fig. 2A). These
results support the physiological significance of PIP3 and
PI4,5P2 binding of Lck-SH2.
Membrane-binding Site of Lck SH2 Domain—Electrostatic
potential computation of Lck-SH2 shows that it has a highly
cationic Tyr(P) binding pocket (red arrow in Fig. 3A) and an
alternative cationic patch (ACP) (green arrow in Fig. 3A) that is
not as electropositive as the Tyr(P) pocket. Previous biochem-
ical (16), structural (28), and computational (29) studies of
some SH2 domains suggested that their Tyr(P) pockets could
bind lipids. However, we found that mutation of the invariant
Arg (Arg-154) in the Tyr(P) pocket of Lck-SH2 to Ala did not
cause a significant decrease in binding to PM mimetic vesicles
(Fig. 1D). In contrast, mutation of ACP residues (Lys-182 and
Arg-184) reduced affinity for PM mimetic vesicles to a much
greater extent (Fig. 1E and Table 1). About a 3-fold decrease in
PM affinity of Lck-SH2 by the K182A/R184A mutation was
comparable with that caused by the R56A/R60A mutation of
PLC-PH (Table 1). These two residues are located on the
membrane binding surface of PLC-PH that is involved in its
nonspecific electrostatic interaction with anionic lipids (30).
These results suggest that not the Tyr(P) pocket but the ACP
serves as the primary lipid-binding site for Lck-SH2. This
notion is supported by the subcellular localization patterns of
Lck-SH2 mutants in HeLa cells, i.e. mutation of Lys-182 and
Arg-184 abrogated its PM localization (Fig. 2C), whereas the
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mutation of Arg-154 had little effect on its PM recruitment
(Fig. 2D).
The ACP of Lck-SH2 does not overlap with any known pro-
tein-binding sites of Lck-SH2, including the secondary binding
site to the Tyr(P) motif (13). Indeed, molecular modeling of
Lck-SH2 suggests that it can bind a lipid headgroup and a
Tyr(P) motif simultaneously and independently (Fig. 3, B and
C). This notionwas verified by its identical Tyr(P) peptide bind-
ingwith andwithout PMmimetic vesicles and unaltered vesicle
binding in the presence of a Tyr(P) peptide (Fig. 4).
To further investigate how Lck-SH2 interacts with mem-
brane lipids, we performed NMR analysis of Lck-SH2-lipid
binding using 15N-labeled Lck-SH2. Although Lck-SH2
showed low PtdInsP selectivity, it still has the highest affinity
for PIP3 (Fig. 1C). We thus used for the solution NMR analysis
a soluble headgroup analog of PIP3, IP4, which has been exten-
sively used for bothNMRand crystallographic analyses. IP4was
selected over a short-chain PIP3 for NMR titration because its
high water solubility allowed cleaner NMR signals and more
straightforward data analysis. Upon binding IP4, major chemi-
cal shift perturbations (CSP) were detected primarily on the
residues located on the molecular surface containing the ACP
(Fig. 3D). Importantly, large CSPs were observed not only with
cationic residues (Arg-134 and Lys-182) but also with aromatic
and hydrophobic residues (e.g. Ala-160, Phe-163, and Ile-183),
suggesting that these residues also contribute to lipid binding of
Lck-SH2. Although IP4 lacks the hydrophobic tail, CSPs were
also observed in these residues presumably because their back-
bone conformational changes, which 15N NMR CSP mainly
monitors, are linked to those of neighboring cationic residues
during lipid binding. In contrast, CSPs were insignificant for
Tyr(P) pocket residues. When Ala-160 was mutated to Lys to
enhance electrostatic binding to anionic PM vesicles, the
A160K mutant had30% higher affinity thanWT, supporting
the notion thatAla-160 constitutes themembrane-binding sur-
face (Table 1). In contrast, mutation of surface residues remote
from the putative membrane-binding site (e.g. K130A and
R207A) had little effect on the affinity of Lck-SH2 to PM vesi-
cles (data not shown). Thus, lipid binding of Lck-SH2 appears
to be driven by the combination of electrostatic and hydropho-
bic interactions, as reported for other lipid binding domains
(24).
FIGURE 1.Membrane binding properties of the Lck SH2 domain. A and B, determination of Kd for Lck-SH2-PMmimetic vesicle binding by SPR analysis. A,
Lck-SH2 was injected at 5l/min at varying concentrations (0, 25, 50, 80, 100, 120, 150, 180, 200, and 250 nM from bottom to top) over the L1 chip coated with
PM mimetic vesicles, and Req values were measured. B, binding isotherm was generated from the Req (average of triplicate measurements) versus the
concentration (Po) of Lck-SH2 plot. A solid line represents a theoretical curve constructed from Rmax ( 470 22) and Kd ( 160 15 nM) values determined by
nonlinear least squares analysis of the isotherm using the following equation: Req Rmax/(1 Kd/Po). Data represent means S.D. from triplicate measure-
ments. C, PtdInsP selectivity of Lck-SH2. Sensorgrams are shown for PIP3 PI4,5P2 PI3,4P2 PI3,5P2 PI5P PI4P PI3P (from top to bottom). D, effect of
mutating cationic residues in the Tyr(P) pocket on membrane binding of Lck-SH2. E, effect of mutating cationic residues in ACP on membrane binding of
Lck-SH2. F, PtdInsP selectivity of PLC-PH. Sensorgrams are shown for PI4,5P2  PIP3  PI3,5P2  PI3P  PI3,4P2  PI4P  PI5P (from top to bottom). SPR
measurements were performed in 20 mM Tris-HCl, pH 7.4, containing 0.16 M KCl. POPC vesicles were used for the control surface. PM mimetic (A and B),
POPC/POPS/PtdInsP (77:20:3) (C and F), and POPC/POPS/PIP3 (77:20:3) (D and E) vesicleswere used as active surfaces. SPRmeasurementswereperformed in 20mM
Tris-HCl, pH 7.4, containing 0.16 M KCl. PM mimetic vesicles contain POPC/POPE/POPS/PI/cholesterol/PI4,5P2 (12:35:22:8:22:1). The Lck-SH2 domain concen-
tration in C–E was 150 nM. Typically, dissociation from the sensor chip was too slow to reach completion within 10 min of elution. Thus, only the association
phases of the sensorgramsare shownhere. All sensorgrams shownherein are representativeof triplicatemeasurements that showessentially the same results.
TABLE 1
Membrane binding properties of Lck, Lck-SH2, andmutants
Proteins Kda
nM
Lck-SH2WTb 160 15
Lck-SH2 K182A/R184Ab 430 10
Lck-SH2 A160Kb 120 10
Lck FLc WT 220 80
PLC-PHWT 240 60
PLC-PH R56A/R60A 480 100
aMeans S.D. were taken from triplicate equilibrium SPR measurements using
PM mimetic vesicles (POPC/POPE/POPS/cholesterol/PI/PI45P2
12:35:22:22:8:1).
b These are EGFP fusion proteins.
c FL means full-length proteins.
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FIGURE 2. Effect of PI4,5P2 and PIP3 manipulation on the subcellular localization of C-terminal EGFP-tagged Lck-SH2. A, PI4,5P2 and PIP3 depletion greatly
reduced PM localization of Lck-SH2. B, PI4,5P2 depletion greatly inhibited PM localization of PI4,5P2-selective EGFP-PLC-PH. C, K182A/R184A showed dramatically
reduced PM localization, which was not affected by PI4,5P2 depletion. D, R154A behaved similarly to WT. The PI4,5P2 depletion was triggered by 2.5 M A/C het-
erodimerizer that recruits FKBP-Inp to PM-anchored Lyn-FRB. All images for PI4,5P2 depletion were taken before and 1 min after heterodimerizer treatment. PIP3
depletion was achieved by pretreating the cells with 50 M LY294002 for 1 h. HeLa cells were used for all measurements. Scale bars, 10 m. Expression levels of
EGFP-Lck-SH2 and EGFP-PLC-PHwere kept as low as possible tominimize the possibility of non-physiological PM localization of proteins due to overexpression.
FIGURE 3. Membrane-binding site of Lck-SH2. A, surface electrostatic potential of Lck-SH2. The Tyr(P) binding pocket and the most prominent ACPs are
indicated by red and green arrows, respectively. Theminimal andmaximal electrostatic potentials are5 kT/e (red) and5 kT/e (blue), respectively. B, location
andmorphologyof the lipid-binding site of Lck-SH2. The structureof Lck-SH2 is shownwith theTyr(P) bindingpocket (redarrow) pointingupward. Key cationic
residues involved in lipid binding are shown in space-filling representation and labeled. C, model structure of Lck-SH2-Tyr(P)-IP4 ternary complex. Lck-SH2
domain (in the sameorientation as inB) is shown in surface representation, and thepeptide (red arrows) and IP4 (greenarrows) are in stick representation.Notice
that there is no steric overlap between the peptide and IP4.D,NMRCSPs for backbone amide signals of
15N-labeled Lck-SH2 observed in the presence of IP4. E,
Lck-SH2 structure (Protein Data Bank code 1LCK) in ribbon representation. The residues with the highest CSPs are shown in light to dark red (top 15%), and the
residues whose NMR signals are missing after IP4 titration are colored in green. Notice that all residues with the largest CSP are on the samemolecular surface
with Lys-182 and Arg-184. A much smaller CSP was observed with the invariant Arg (R154) and neighboring residues in the Tyr(P) binding pocket.
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Role of Lipid Binding of Lck SH2Domain inTCell Signaling—
To investigate the physiological significance of the lipid binding
activity of Lck-SH2, we measured the effects of altering lipid
binding of Lck on its TCR signaling activities. Because Lck-SH2
has high affinity for PM mimetic vesicles (Table 1) and mod-
estly prefers PIP3 and PI4,5P2 to other PtdInsPs (Fig. 1C), both
PI4,5P2 that is constitutively present in the PM and PIP3 whose
production in the PM is induced by cell stimuli might contrib-
ute to its PM binding. For functional studies of Lck, we pre-
pared a lipid-binding loss-of-function (LOF) mutant (K182A/
R184A) and a gain-of-function (GOF) mutant (A160K) (Table
1). Neithermutation alteredTyr(P) binding of Lck-SH2 (Fig. 5).
We then compared the effects of introducing WT and
mutants of Lck to Lck-deficient (JCaM1.6) Jurkat cells on TCR
signaling activities. We first monitored the increase in calcium
flux in JCaM1.6 cells (Fig. 6A). When stimulated with an anti-
CD3 antibody, OKT3, JCaM1.6 cells showed no calcium flux,
which was greatly increased by stable expression of Lck WT.
Under the same conditions, K182A/R184A had 40% of the
LckWT activity (Fig. 6A), whereas theGOFmutant A160Kwas
30%more active than theWT (Fig. 6B). Furthermore, K182A/
R184A was much less effective than WT in inducing OKT3-
stimulated Tyr phosphorylation of downstream proteins,
ZAP70, PLC, and ERK1/2 (Fig. 6C). In contrast, A160K
showed 30% higher activity than WT in the ERK Tyr phos-
phorylation assay (Fig. 6D). It should be noted that for accurate
comparison of signaling activities of WT and A160K, it was
critical to use stable cell lines with similar expression levels for
our activity assays. To compensate for the differences in expres-
sion levels of WT and the GOF mutant, we thus gated cells
expressing similar levelsofGFP-taggedproteinsby flowcytometry
and used them for quantitative analysis. Finally, we measured the
signaling activity of a Tyr(P) binding-deficient mutant of Lck
(R154A) as controls. As expected, it showed much reduced bind-
ing for Tyr(P) peptides (Fig. 5), and no detectable activity in all
assays (Fig. 6,A andC). Collectively, strong correlation between in
vitromembrane binding affinity of LckWT and lipid-binding site
mutants with their cellular signaling activities supports the notion
that lipid binding of its SH2 domain is important for the cellular
regulation and function of Lck.
Mechanisms by Which Lipids Regulate Lck Function—Lck
has been reported to interact with various proteins involved in
TCR signaling (1–3, 31). To better understand how lipid-binding
site mutations of Lck caused observed cellular phenotypes, we
determined how lipids modulate the interaction of Lck with the
TCR  chain whose ITAMs serve as a substrate for Lck in the
activated TCR-CD3 complex (1–3). We employed two-color sin-
gle molecule tracking for this study, because it can quantitatively
and sensitivelymonitor dynamic and transient interaction among
signaling proteins, which cannot be detected by conventional bio-
chemical methods, such as coimmunoprecipitation (20, 32). We
first transfected theSNAP-tagged chain into JCaM1.6cells stably
expressing EGFP-LckWT, labeled the SNAP tag with tetrameth-
ylrhodamine (TMR), and tracked two proteins simultaneously.
BecauseTCR- is a transmembraneproteinandLck ismembrane-
anchored by N-terminal myristoylation and palmitoylation, both
proteins show typical lateral diffusion in the PM, but their trajec-
tories exhibited a low degree of overlap in resting cells, showing
lack of colocalization (Fig. 7A).
When cells were stimulated with OKT3, which should trig-
ger the release of the Lck SH2 domain from intramolecular
tethering (Fig. 8) (1, 2), dynamic Lck- colocalization was sig-
nificantly enhanced within 5 min, which lasted for 10 min
(Fig. 7, A and B, and a black line inD). However, dynamic colo-
calization of the Lck LOF mutant (K182A/R184A) with TCR-
was only slightly and briefly increased after OKT3 stimulation
(Fig. 7, A and C, and a red line in D). In contrast, the GOF
mutant A160K exhibited more extensive OKT3-induced colo-
calization with TCR- than WT (blue line in Fig. 7D). Intrigu-
ingly, pretreatment of JCaM1.6 cells with a PI3K inhibitor,
LY294002, did not have a detectable effect on initial Lck-TCR-
colocalization up to 5 min but significantly reduced the colo-
calization thereafter (green line in Fig. 7D). This implies that the
Lck-PIP3 interaction takes maximal effect 5 min after OKT
stimulation under our experimental conditions and that it is
important for sustaining interaction between Lck and TCR-.
Finally, we monitored the OKT3-induced dynamic colocaliza-
tion of the Tyr(P) binding-deficient mutant, R154A, with
TCR-, and it consistently showed much lower colocalization
with TCR- than WT (Fig. 7E). This result indicates that Lck
interacts with TCR- via its SH2 domain. More importantly,
our results indicate that binding of PM lipids via its SH2domain
is essential for the dynamic interaction of Lck with TCR- upon
TCR activation, although both proteins are prelocalized at the
PM. Also, binding of Lck-SH2 to PIP3 produced by PI3K acti-
vation might be important for sustained interaction between
Lck and TCR- and sustained activation of Lck.
Discussion
This study provides newmechanistic insight into Lck activa-
tion in response to TCR stimulation by demonstrating that its
SH2 domain mediates interaction of Lck with its binding part-
ners in the activated TCR complex in a lipid-dependent man-
ner. Our SPR analysis clearly shows that Lck-SH2 can bind PM
lipids with high affinity, albeit with low lipid headgroup speci-
FIGURE 4. Orthogonal functionality of lipid and peptide binding sites of
Lck-SH2. A, binding of Lck-SH2 to the Tyr(P) peptide (pYEEI) monitored by
fluorescence anisotropy in the presence () and absence (E) of 40 M PM
mimetic vesicles. The peptide concentration was 50 nM. Notice that vesicles
have no effect on peptide binding of Lck-SH2. Data represent means S.D.
from triplicate measurements. B, effect of the Tyr(P) peptide on membrane
binding of Lck-SH2. The SH2 domain was allowed to interact with the PM
mimetic vesicles before and after a 30-min incubation with 100 M peptide.
The Lck-SH2 domain concentration was 50 nM. The peptide had a negligible
effect on the membrane binding of Lck-SH2, showing the orthogonality of
lipid and peptide binding. Sensorgrams are a representative from triplicate
measurements that show essentially the same results.
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ficity. Consistent with its membrane binding properties, elec-
trostatic potential calculation, mutational analysis, and NMR
analysis of Lck-SH2 indicate that it neither uses its Tyr(P) bind-
ing pocket for lipid binding nor has a well defined lipid binding
pocket. Instead, Lck-SH2 employs the ACP and surrounding
aromatic and hydrophobic residues for membrane binding.
This type of relatively flat membrane-binding sites containing
basic, hydrophobic, and aromatic residues has been reported
for other lipid binding domains with low lipid headgroup spec-
ificity, such as AP180 N-terminal homology domains (33, 34).
As is the case with AP180 N-terminal homology domains (33),
Lck-SH2 effectively binds PtdInsPs, most notably PIP3 and
PI4,5P2.
Our recent study showed that the molecular location and
morphology of lipid-binding sites in SH2 domains are highly
variable even among related proteins, which allows SH2
domains to adopt different modes of lipid and Tyr(P) binding
that ideally suit their different cellular functions (22). For each
SH2 domain, however, the conservation of lipid-binding resi-
dues among species is extremely high (22). This is true for Lck-
SH2 as multiple sequence alignment demonstrates that all
known orthologs of Lck-SH2 have basic residues at positions
182 and 184 (supplemental Fig. S1).
Many TCR signaling activities of Lck, including Tyr phos-
phorylation of ZAP70, PLC, and ERK1/2, as well as the intra-
cellular calcium flux mediated by PLC, were all significantly
FIGURE5.Tyr(P)bindingaffinityof Lck-SH2WTandmutants.Affinity of Lck-SH2WT (E), R154A (Tyr(P) sitemutant) (), K182A/R184A (LOF lipid sitemutant)
(), and A160K (GOF lipid site mutant) (f) for three different Tyr(P)-containing peptides, pYEEI (A), pYSDPE (B), and pYQPQP (C), that have been reported to
specifically bind the Lck-SH2 was measured by fluorescence anisotropy analysis as described in Fig. 4. For all three peptides, Lck-SH2 WT (Kd 33 7 nM for
pYEEI), K182A/K184A (Kd 40 8 nM for pYEEI), and A160K (Kd 32 3 nM for pYEEI) showed comparable affinity, whereas R154A (Kd 570 200 nM for
pYEEI) exhibited a20-fold decrease in affinity. Thepeptide concentrations used varied from5 to 500nMdependingon the Kd values. Data representmeans
S.D. from triplicate measurements.
FIGURE 6. Lipid binding activity of Lck-SH2 domain is crucial for T cell signaling activities of Lck. A, calciummobilization; C, Tyr phosphorylation of TCR
signaling proteins in JCaM1.6 cells stably transduced with EGFP-tagged Lck WT and mutants after TCR stimulation. For calcium flux assay, cells were labeled
with 4 g/ml Indo-1 AM, and the calcium flux was monitored for 8 min after OKT3 (1 g/ml) treatment by flow cytometry. For Tyr(P) monitoring, cells were
stimulated with OKT3 (10 g/ml for 5 min), and cell lysates were immunoblotted with indicated antibodies. B, calcium mobilization in JCaM1.6 cells stably
transducedwithEGFP-taggedLckWTandA160K, respectively, after TCR stimulationwith0.1g/mlOKT3.D, JCaM1.6 cells stably transducedwithEGFP-tagged
Lck WT and A160K were stimulated with indicated doses of OKT3 for 5 min, and the levels of pERK1/2 were measured by intracellular staining and flow
cytometry. To compensate for the differences in expression levels of WT and GOFmutants, cells expressing similar levels of EGFP-tagged proteins were gated
and used for quantitative analysis. All data are from triplicate measurements that show essentially the same results. D, data represent means S.D. ***, p	
0.001 from Student’s t test.
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compromised by the LOF lipid-binding mutation of Lck while
enhanced by the GOFmutation. Excellent correlation between
their in vitro lipid binding properties with their cellular activi-
ties, enhanced cellular activities of the GOF mutant in par-
ticular, shows that the lipid binding activity of Lck-SH2 is
essential for the TCR signaling activity of Lck and also
makes it unlikely that the observed cellular phenotypes
derive from lipid-independent effects, such as altered terti-
ary structures or post-translational modification of Lck
caused by mutations.
FIGURE 7. Single molecule tracking of Lck and TCR- in the TCR complex. A, representative images of Lck-GFP (WT and K182A/R184A) and SNAP-TMR-
labeledTCR- in a JCaM1.6 cell before andafterOKT3 stimulationare shown.Green, red,and yellow linesare trajectories of Lck, TCR-, and colocalizedmolecules,
respectively. Arrows indicate the starting points of tracking. The scale bar indicates 1m. B and C, time courses of dynamic colocalization of SNAP-TMR-TCR-
and Lck-GFP (WT and K182A/R184A). The histograms display percentages of TCR-molecules spending a given colocalization time (0.2 s) with Lck on the PM
of JCaM1.6 cells.D and E, time courses of the half-life of colocalization for Lck-GFP proteins and SNAP-TMR-TCR-. The half-life of colocalizationwas calculated
from thedissociation rate constant (k), whichwasdeterminedbynon-linear least squares analysis of histogramsusing a single-exponential decay equation (i.e.
P Po e
kt). The same size of PM surface was analyzed for each histogram. Error bars indicate S.D. (n 50–100).
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Lck is prelocalized in the PM via N-terminal acylation, and
lipids should thus play more complex roles than simple mem-
brane recruitment of Lck. Our singlemolecule imaging analysis
shows that lipid binding of the SH2 domain regulates spatio-
temporally specific interaction of Lck with TCR- in the TCR
signaling complex. Although Lck has been reported to interact
with various proteins involved in TCR signaling (1–3, 31), it is
not fully understood whether and how Lck-SH2 is involved in
specific interaction with proteins in the TCR-CD3 complex.
Because the ITAM inTCR- is a substrate for Lck, however, Lck
should directly interact withTCR- (35). Singlemolecule track-
ing of the Tyr(P) binding-deficient mutant, R154A, confirms
that Lck-TCR- interaction is indeed mediated by Lck-SH2. In
this regard, it is interesting to find that LckWT and LOF/GOF
lipid-binding mutants, which have essentially the same affinity
for Tyr(P)-containing peptides (see Fig. 5), show distinctly dif-
ferent dynamic colocalization with TCR- in the cell in accord-
ance with their different in vitro lipid binding activity. Clearly,
Lck and TCR- cannot effectively interact with each other
without Lck-SH2 lipid binding, although both proteins are
anchored to the PM. The question arises then as to how exactly
PM lipids control interaction of Lck with TCR- (and other
proteins) in the TCR-CD3 complex.
On the basis of reported properties of Lck and our data pre-
sented herein, one can speculate at least two different mecha-
nisms bywhich PM lipids regulate interaction of Lckwith other
proteins, including TCR-, in the TCR-CD3 complex and its
TCR signaling activities. Membrane lipids are known to regu-
late interactions among membrane-associated proteins by
modulating their conformations and membrane-bound orien-
tations (36). It is thus possible that lipid binding of Lck-SH2
induces conformational changes of Lck in such a way to align
Lck-SH2 for optimal interaction with the Tyr(P) motif in the
target proteins while preventing its intramolecular interaction
with Tyr(P)-505 that would lead to Lck inactivation (see Fig. 8).
It was reported that a conformational change takes place when
enzymatically activeTyr(P)-394/Tyr(P)-505-Lck,which consti-
tutes 25% of Lck population in T cells, is activated for TCR
signaling (8, 9). It is possible that lipid-mediated conforma-
tional changes represent the mechanism to keep this species
active (see Fig. 8). Also, PIP3 might control signaling activities
of Lck and its interactionwith protein partners in a spatially and
temporally specificmanner. Because of high affinity of Lck-SH2
for PIP3, PIP3 produced via PI3K activation, which is down-
stream of Lck activation (4, 5), might serve as a positive feed-
backmechanism to control the duration of Lck activation. Fur-
thermore, PIP3 has been reported to be enriched in the region
of the activated TCR complex (37), and thus PIP3 might allow
Lck to be dynamically co-localized with the TCR-CD3 com-
plex. Ithasbeenreported that c-Srccatalyzes themultisitephos-
phorylation of its substrates in a processive manner via its SH2
domain that binds to Tyr(P) of partially phosphorylated sub-
strates (38). Although it is not knownwhether Lck catalyzes the
multisite phosphorylation processively under physiological
conditions (10), PIP3-mediated sustained interaction of Lck
with TCR- and other proteins should contribute to its pro-
cessive catalysis. Undoubtedly, further studies are needed to
fully answer these complex mechanistic questions, and our
results provide a new conceptual framework for further mech-
anistic studies of Lck activation and TCR signaling.
Experimental Procedures
Materials—1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoetha-
nolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoserine (POPS), cholesterol, and liver phosphoinositol (PI)
were purchased from Avanti Polar Lipids. 1,2-Dipalmitoyl
derivatives of phosphatidylinositol 4,5-bisphosphate (PI4,5P2),
phosphatidylinositol 3,4,5-trisphosphate (PIP3), phosphatidyl-
inositol 3,4-bisphosphate (PI3,4P2), phosphatidylinositol 3,5-bis-
FIGURE 8. Hypothetical model for spatiotemporal coordination of protein interaction and signaling activity of Lck by PM lipids during T cell activa-
tion. Lck is PM-localizedbyN-terminal lipidation (orange lines) but remains inactivedue to intramolecular tetheringof its catalytic domain (Kin) by SH2andSH3
domains. Upon TCR activation, dephosphorylation of Tyr-505 by CD45 unleashes Lck-SH2 from the catalytic domain and allows its interaction with PM lipids,
including PI4,5P2 (green hexagon) and autophosphorylation on Tyr-394 for full enzymatic activation. Lipid-Lck-SH2 binding is crucial for spatiotemporally
specific interaction of Lck with proteins in the activated TCR-CD3 complex, including the  chain, and for preventing inactivation of another active species,
Tyr(P)-394/Tyr(P)-505, by Tyr(P)-505-Lck-SH2 intramolecular tethering. Both Lck-Tyr(P)-394 and Lck-Tyr(P)-394/Tyr(P)-505 can effectively phosphorylate ITAMs
in the CD3 and  chains to initiate the TCR signaling. PIP3 (red hexagon), which is subsequently produced by PI3K and accumulated near the TCR-CD3 complex,
allows sustained activation of Lck via its tight interaction with Lck-SH2.
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phosphate (PI3,5P2), phosphatidylinositol 3-monophosphate
(PI3P), phosphatidylinositol 4-monophosphate (PI4P), and
phosphatidylinositol 5-monophosphate (PI5P) were from Cay-
man Chemical Co. D-Myo-inositol-(1,3,4,5)-tetrakisphosphate
(IP4) was also from Cayman. The human anti-CD3 antibody,
OKT3, was purchased from Bio X Cell, and anti-GFP antibody
and anti-actin antibody were from Santa Cruz Biotechnology
and Bethyl Laboratories, respectively. All other antibodies were
from Cell Signaling Technologies. Phosphoinositide 3-kinase
(PI3K) inhibitor, LY294002, was from Sigma.
DNA Constructs—cDNAs of full-length human Lck and
TCR- (CD247) were subcloned to the pSNAPf vector (New
England Biolabs) using KpnI/XhoI and EcoRI/EcoRV sites,
respectively.
Protein Expression and Purification—All EGFP-tagged Lck-
SH2 and full-length Lck proteinswere expressed asHis6-tagged
proteins in Escherichia coli BL21 (DE3) pLysS (Novagen). Cells
were cultured to an A600 of 
0.6, and protein expression was
induced by adding 0.5–1mM isopropyl--D-1-thiogalactopyra-
noside at 16 °C for 12 h. The transformed cells were harvested
by centrifugation at 4 °C, and cell pellets were resuspended in
the lysis buffer (50 mM Tris-HCl, pH 7.9, 0.3 M NaCl, 10 mM
imidazole, 10% glycerol, 1 mM 4-(2-aminoethyl)benzen-
esulfonyl fluoride) and lysed by sonication. TheHis-tagged pro-
teins were purified using the nickel-nitrilotriacetic acid-aga-
rose resin (Qiagen). Eluted proteins were further treated on a
PD-10 desalting column (GE Healthcare) equilibrated with 20
mM Tris-HCl, pH 7.4, 0.16 M NaCl. Proteins were quantified by
the Bradford assay (Bio-Rad).
Lipid Vesicles Preparation and SPR Analysis—PM mimetic
vesicles were prepared by mixing POPC, POPE, POPS, choles-
terol, PI, and PI4,5P2 in amolar ratio of 12:35:22:22:8:1 (39). All
SPR measurements were performed at 23 °C using a lipid-
coated L1 chip in the BIAcore X and T100 systems as described
(40, 41). 20 mM Tris-HCl, pH 7.4, containing 0.16 M NaCl was
used as the running buffer, whereas PM mimetic vesicles and
POPCvesicleswere coated on the active surface and the control
surface, respectively. Equilibrium measurements were per-
formed at a flow rate of 10l/min. At least five different protein
concentrations were injected to collect a set of Req values that
were plotted against the protein concentrations (Po). An appar-
ent dissociation constant (Kd) was then determined by nonlin-
ear least squares analysis of the binding isotherm using the
equation, Req  Rmax/(1  Kd/Po), where Rmax indicates the
maximalReq value (42). For kineticmeasurements, the flow rate
was maintained at 20–30 l/min.
PI4,5P2 and PIP3 Depletion—The PI4,5P2 depletion was per-
formed in HeLa cells according to a reported procedure (26,
27). Themethod uses the Lyn-based PM-anchored FKBP12-ra-
pamycin binding (FRB) domain of the mechanistic target of
rapamycin (Lyn-FRB) and the FK506-binding protein-12-yeast
inositol polyphosphate 5-phosphatase domain fusion protein
(FKBP-Inp). To monitor PM translocation of EGFP-tagged
Lck-SH2WTandmutants and PLC-PHwith this system, Lyn-
FRB and FKBP-Inp were used without fluorescence protein tag
(43). 2.5 M rapamycin analog, A/C heterodimerizer (Clon-
tech), was used to trigger the PI4,5P2 depletion. PIP3 depletion
was achieved by pretreating the cells with 50 M LY294002
for 1 h.
Stable Cell Line Preparation—A Jurkat cell line derivative,
JCaM1.6 (CRL-2063), was purchased fromATCC and cultured
in RPMI 1640medium containing 5% FBS.Wild type (WT) and
mutant Lck-GFP were stably expressed in JCaM1.6 by retrovi-
ral gene transduction. A retroviral construct, pMSCVneo-
hLck-GFP,was cloned by PCR, and pointmutationswere intro-
duced by site-directed mutagenesis. Retrovirus preparation
and transduction were performed as described previously (44).
Cell Signaling Activity Assays—Changes in the intracellular
calcium levels were assessed by flow cytometry. Cells were
loaded with 4 g/ml Indo-1 AM (Life Technologies, Inc.) in
RPMI 1640 media containing 5% fetal bovine serum for 30 min
at 37 °C, washed, and resuspended in RPMI 1640 medium sup-
plemented with 25 mM HEPES and 2% fetal bovine serum at a
cell density of 2  106/ml. The changes in the fluorescence
emission ratio of the calcium-bound versus -unbound form of
Indo-1 were measured using LSR Fortessa (BD Biosciences).
Baselinemeasurements were conducted for 1min, and calcium
flux wasmonitored for an additional 8 min after the addition of
OKT3. The data were analyzed with FlowJo software (TriStar).
Tyr Phosphorylation Assay—Cells expressing either WT or
mutant Lck-GFP were stimulated with OKT3 at 37 °C for the
indicated time. Cells were then immediately lysed by addition
of ice-cold radioimmunoprecipitation assay buffer supple-
mented with a protease inhibitor mixture and a protein phos-
phatase inhibitor mixture. The proteins were separated by
SDS-PAGE, transferred to a nitrocellulose membrane, and
probed with the indicated antibodies. The chemiluminescence
was detected with ImageQuant LAS 4000 (GE Healthcare).
pERK1/2 Intracellular Staining—After TCR stimulation,
cells were fixed with 3.7% formaldehyde for 10 min, washed
with FACS buffer (phosphate buffer saline containing 2%
bovine serumalbumin and 0.1%NaN3), and permeabilizedwith
methanol for 30 min on ice. After washing with FACS buffer,
the fixed cells were incubated with mouse anti-pERK1/2 for 45
min at room temperature, washed, and then incubated with
Alexa Fluor 647-conjugated goat anti-mouse IgG antibody for
30 min at room temperature. The levels of pERK1/2 were mea-
sured by flow cytometry.
SH2-Peptide Binding Assay by Fluorescence Anisotropy—Flu-
orescein-6-aminohexanoyl (F-Ahx)-labeled peptides used for
binding studies are F-Ahx-pYEEI, F-Ahx-pYSDPE, and F-Ahx-
pYQPQP. The peptide was dissolved in 20 mM Tris buffer, pH
7.4, containing 160 mM NaCl, and 5% dimethyl sulfoxide. To
each well of a 96-flat bottom black polystyrol plate was added
100 l of solution containing each peptide (5 nM) and SH2
domain (2.5 nM to 25 M) with or without 150 M PM vesicles.
After 30 min of incubation, the plate was inserted into BioTek
Synergy Neo microplate reader, and the fluorescence anisot-
ropy (r) was measured with excitation and emission wave-
lengths set at 485 and 535 nm, respectively. Because under our
conditions, Po Pepo, the Kd value for the SH2 domain-pep-
tide binding was determined by the non-linear least squares
analysis of the binding isotherm using Equation 1,
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Pepbound/Pep0 	 r/ramx	
1
1
 Kd/P0
(Eq. 1)
where Pepbound, Pepo, and Po indicate the concentration of
bound peptide, total peptide, and total SH2 domain, respec-
tively, and r and rmax are the anisotropy change for each Po
and the maximal r, respectively.
Single Molecule Tracking by Total Internal Reflection Fluo-
rescenceMicroscopy—Simultaneous singlemolecule imaging of
two proteins was performed in Jurkat cells using a total internal
reflection fluorescence microscope as described previously
(20). JCaM1.6 Jurkat cells stably expressing Lck-GFP WT (or
mutants) were transiently transfected with SNAP-tagged
TCR- chain,whichwas subsequently labeledwith SNAP-Cell
TMR-Star (New England Biolabs). Labeled cells were washed,
attached to a poly-L-lysine-coated glass plate for imaging, and
stimulated with 10g/ml OKT3, and Lck and molecules were
simultaneously tracked. To see the effect of PIP3 depletion on
interaction between Lck WT and TCR-, cells were pretreated
with 50 M LY294002 for 1 h before OKT3 stimulation. All
particle tracking, data analysis, and image processing were car-
ried out with in-house programs written inMATLAB. Colocal-
ization analysis of two molecules was performed with a fixed
threshold criterion (i.e. 	400 nm) for colocalization (32). The
same size of PM surface was analyzed for each data. The per-
centage of TCR- molecules spending a given colocalization
time (0.2 s) with Lck on the PMwas calculated from the total
number of TCR-molecules and displayed as a histogram. Data
were fit into a single exponential decay equation (i.e. P  Po
ekt) to determine the dissociation rate constant (k) values by
non-linear least squares analysis, and the half-life values of
colocalization were calculated as ln2/k. 50–100 images were
analyzed for each data point.
Electrostatic Analysis—The ProteinData Bank files were pre-
pared for further calculations using PDB2PQR interface (45,
46). We used PROPKA (47, 48) to predict protonation states of
protein residues. DelPhi (49) was used for assigning electro-
static potentials to the atoms of the structures. Only linear Del-
Phi iterations were run. Both PROPKA and Delphi used
CHARMM force field (50). The calculated potentials were
loaded into GRASP2 (51) for subsequent visualization.
Docking—Docking of the lipids to the structure of SH2
domains was performed with the DOCK program of the pack-
age DOCK 6 (52, 53). The spheres representing the binding site
were selected within 7 Å from the side chains of the residues
shown to be important for the lipid binding. The ligand was
allowed to be flexible during the orientation step. The topmost
pose generated by DOCK run was rescored using Amber score
program, which allows both the ligand and the active site of the
receptor to be flexible (54).
Multiple Sequence Alignments—Multiple sequence align-
ments were generated with Clustal 2.0.10 (55).
NMR Data Acquisition and Processing—The 1H,15N-HSQC
experiments were recorded at 600- and 800-MHz on Bruker
Avance spectrometers at 20 °C. The samples contained 0.1, 0.5,
or 1mM 15N-labeled Lck-SH2 in 25mMpotassiumphosphate, 2
mM dithiothreitol, and 5% deuterium oxide, pH 7.2. IP4 was
titrated to a final concentration of 1 mM. All NMR data were
processed with NMRpipe (56) and analyzed with CARA. The
chemical shift perturbations, , upon addition of IP4 were
calculated from 1H and 15N chemical shifts using a weighted
averaging scheme previous described by Grzesiek et al. (57).
Missing shifts are indicative of either unavailable experimental
data, because of peak overlap, or a residue position occupied by
a proline.
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